Duplin General Hospital Incorporated

Duplin General Hospital Incorporated was paid $13.59M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.

33Billing provider infoDUPLIN GENERAL HOSPITAL INCORPORATED
KENANSVILLE, NC 28349

33aNPI1508832833assigned 02/27/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$13.59M

24GClaims208,437

24DCodes billed93

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#41 of 92

Median peer was paid$11.47M

This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	30,579	$1.31M
2019	27,136	$1.35M
2020	17,911	$1.06M
2021	24,461	$1.74M
2022	33,804	$2.86M
2023	32,839	$2.46M
2024incomplete	41,707	$2.80M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	26%	32,214	30,671	$3.50M
41899	Unlisted procedure, dentoalveolar structures	16%	2,184	2,086	$2.17M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	16%	17,589	16,606	$2.16M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	9.0%	7,087	6,792	$1.22M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.7%	6,706	6,320	$770K
71046	Radiologic examination, chest; 2 views	3.4%	6,176	5,959	$462K
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.8%	5,500	5,295	$385K
70450	Computed tomography, head or brain; without contrast material	2.3%	1,539	1,454	$313K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.9%	283	268	$260K
71045	Radiologic examination, chest; single view	1.7%	4,050	3,803	$233K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.4%	6,789	6,363	$188K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.4%	5,357	4,943	$186K

81 more codes

C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.3%	6,218	$175K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.0%	19,683	$140K
0225U		1.0%	354	$140K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,535	$130K
80053	Comprehensive metabolic panel	<1%	15,262	$122K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,402	$94K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,415	$93K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,846	$88K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,217	$79K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,844	$73K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,844	$73K
81025		<1%	5,871	$50K
84484		<1%	4,226	$37K
J3490	Unclassified drugs	<1%	3,121	$35K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	753	$34K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,527	$29K
81001		<1%	8,550	$28K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	802	$22K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	27	$21K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	551	$21K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	726	$19K
36410		<1%	717	$19K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,453	$16K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	92	$14K
81003		<1%	5,050	$14K
83690		<1%	1,662	$13K
87088		<1%	1,324	$11K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,365	$9K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,103	$9K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	339	$9K
87430		<1%	626	$8K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,804	$8K
83735		<1%	1,384	$8K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,188	$7K
87807		<1%	489	$6K
84443	Thyroid stimulating hormone (TSH)	<1%	379	$5K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	178	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	178	$5K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,106	$5K
85610		<1%	1,435	$4K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	604	$4K
A4217	Sterile water/saline, 500 ml	<1%	332	$4K
83880		<1%	163	$4K
86141		<1%	229	$3K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	121	$3K
87077		<1%	294	$3K
87070		<1%	246	$2K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	12	$2K
86850		<1%	186	$2K
87081		<1%	331	$2K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	24	$2K
85027		<1%	229	$2K
86592		<1%	353	$2K
83605		<1%	145	$2K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	14	$1K
86762		<1%	92	$1K
86787		<1%	92	$1K
87340		<1%	113	$1K
82962		<1%	381	$976.05
86901		<1%	190	$972.02
86900		<1%	190	$972.02
J2704	Injection, propofol, 10 mg	<1%	264	$936.72
94664		<1%	59	$879.59
87040		<1%	65	$860.98
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	173	$789.66
83036	Hemoglobin; glycosylated (A1C)	<1%	75	$785.85
82077		<1%	160	$678.24
85379		<1%	69	$627.50
J3535	Drug administered through a metered dose inhaler	<1%	13	$609.78
85730		<1%	145	$605.47
87186		<1%	72	$600.08
85660		<1%	93	$529.76
74018		<1%	13	$360.36
82728		<1%	26	$291.94
84466		<1%	26	$250.09
82550		<1%	56	$242.12
84702		<1%	15	$163.50
83540		<1%	26	$127.04
86140		<1%	26	$103.20
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	588	$61.96
87210		<1%	12	$39.92

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCRAWFORD, LUCINDA (CFO)